{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-08-29T07:02:38.661680+00:00","company":{"ticker":"RAPH","cik":1415397,"company_name":"Raphael Pharmaceutical Inc."},"pagination":{"limit":100,"returned":6,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"executive_change","fact_key":"c8e3e1ea8e","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2026-07-17T13:20:50+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-07-16","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Uri Tadelis was appointed as Chief Financial Officer at Raphael Pharmaceutical Inc..","evidence_excerpt":"Effective July 16, 2026, the Company appointed Mr. Uri Tadelis as its Chief Financial Officer.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-078937","anchor_url":"https://secwatch.observer/filing/0001213900-26-078937#claim-c8e3e1ea8e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390026078937/0001213900-26-078937-index.htm"},{"fact_type":"executive_change","fact_key":"218017ef98","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2026-07-17T13:20:50+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-07-16","interim":false,"role":"Chief Financial Officer, General Counsel, and Director","role_category":"cfo","successor_name":"Uri Tadelis","successor_named":true},"claim":"Guy Ofir resigned as Chief Financial Officer, General Counsel, and Director at Raphael Pharmaceutical Inc..","evidence_excerpt":"Mr. Guy Ofir voluntarily resigned from his positions as Chief Financial Officer, General Counsel, and Director of the Company, effective July 16, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-078937","anchor_url":"https://secwatch.observer/filing/0001213900-26-078937#claim-218017ef98","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390026078937/0001213900-26-078937-index.htm"},{"fact_type":"executive_change","fact_key":"202aaaabac","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2026-07-17T13:20:50+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-06-30","interim":false,"role":"Chairman of the Board of Directors","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Ajay Kumar Dhadha resigned as Chairman of the Board of Directors at Raphael Pharmaceutical Inc..","evidence_excerpt":"Mr. Ajay Kumar Dhadha voluntarily resigned from his positions as Chairman of the Board of Directors and Director of the Company, effective June 30, 2026.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-078937","anchor_url":"https://secwatch.observer/filing/0001213900-26-078937#claim-202aaaabac","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390026078937/0001213900-26-078937-index.htm"},{"fact_type":"executive_change","fact_key":"eb4876e557","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2025-01-14T23:59:59+00:00","payload":{"action":"replaced","action_category":"role_change","departure_tone":"routine","effective_date":"2025-01-08","interim":false,"role":"Chairman","role_category":"chair","successor_name":"Ajay Kumar Dhadha","successor_named":true},"claim":"Shlomo Pilo changed role as Chairman at Raphael Pharmaceutical Inc..","evidence_excerpt":"The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-25-003401","anchor_url":"https://secwatch.observer/filing/0001213900-25-003401#claim-eb4876e557","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm"},{"fact_type":"executive_change","fact_key":"0ea5524fa2","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2025-01-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-08","interim":false,"role":"Director and Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Ajay Kumar Dhadha was appointed as Director and Chairman at Raphael Pharmaceutical Inc..","evidence_excerpt":"The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-25-003401","anchor_url":"https://secwatch.observer/filing/0001213900-25-003401#claim-0ea5524fa2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm"},{"fact_type":"executive_change","fact_key":"32befa6733","cik":1415397,"ticker":"RAPH","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2022-07-07T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-06-30","interim":false,"role":"Chairman of the Board of Directors","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Joseph Press resigned as Chairman of the Board of Directors at Raphael Pharmaceutical Inc..","evidence_excerpt":"On June 30, 2022, Prof. Joseph Press informed the Company that he intended to resign from the Board of Directors, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-22-037819","anchor_url":"https://secwatch.observer/filing/0001213900-22-037819#claim-32befa6733","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1415397/000121390022037819/0001213900-22-037819-index.htm"}]}